Adverse Event Clinical Research
1.0.1 - STU1 International flag

Adverse Event Clinical Research, published by HL7 International / Biomedical Research and Regulation. This guide is not an authorized publication; it is the continuous build for version 1.0.1 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/fhir-ae-research-ig/ and changes regularly. See the Directory of published versions

: medication-request-example-tucatinib - JSON Representation

Page standards status: Informative

Raw json | Download


{
  "resourceType" : "MedicationRequest",
  "id" : "medication-request-example-tucatinib",
  "text" : {
    "status" : "generated",
    "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative: MedicationRequest</b><a name=\"medication-request-example-tucatinib\"> </a><a name=\"hcmedication-request-example-tucatinib\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource MedicationRequest &quot;medication-request-example-tucatinib&quot; </p></div><p><b>status</b>: active</p><p><b>intent</b>: order</p><h3>Medications</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Concept</b></td></tr><tr><td style=\"display: none\">*</td><td>tucatinib 150 MG Oral Tablet <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://terminology.hl7.org/5.5.0/CodeSystem-v3-rxNorm.html\">RxNorm</a>#2361290)</span></td></tr></table><p><b>subject</b>: <a href=\"Patient-patient-example-kaitlyn-b.html\">Patient/patient-example-kaitlyn-b</a> &quot; BOUNCE&quot;</p><p><b>authoredOn</b>: 2020-03-12</p><p><b>requester</b>: <a href=\"Practitioner-practitioner-owen-oncologist.html\">Practitioner/practitioner-owen-oncologist</a> &quot; ONCOLOGIST&quot;</p><blockquote><p><b>dosageInstruction</b></p><p><b>text</b>: oral twice a day every day</p><p><b>timing</b>: Starting 2020-04-01, Once</p><p><b>route</b>: Oral route (qualifier value) <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"https://browser.ihtsdotools.org/\">SNOMED CT</a>#26643006)</span></p><blockquote><p><b>doseAndRate</b></p></blockquote><p><b>maxDosePerAdministration</b>: 2</p></blockquote></div>"
  },
  "status" : "active",
  "intent" : "order",
  "medication" : {
    "concept" : {
      "coding" : [
        {
          "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
          "code" : "2361290",
          "display" : "tucatinib 150 MG Oral Tablet"
        }
      ]
    }
  },
  "subject" : {
    🔗 "reference" : "Patient/patient-example-kaitlyn-b"
  },
  "authoredOn" : "2020-03-12",
  "requester" : {
    🔗 "reference" : "Practitioner/practitioner-owen-oncologist"
  },
  "dosageInstruction" : [
    {
      "text" : "oral twice a day every day",
      "timing" : {
        "repeat" : {
          "boundsPeriod" : {
            "start" : "2020-04-01"
          }
        }
      },
      "route" : {
        "coding" : [
          {
            "system" : "http://snomed.info/sct",
            "code" : "26643006",
            "display" : "Oral route (qualifier value)"
          }
        ]
      },
      "doseAndRate" : [
        {
          "rateQuantity" : {
            "value" : 150,
            "unit" : "MG",
            "system" : "http://unitsofmeasure.org",
            "code" : "MG"
          }
        }
      ],
      "maxDosePerAdministration" : {
        "value" : 2
      }
    }
  ]
}